presence of plasma hypotonicity, and renal salt loss in the absence of renal and adrenal disease.
In normal subjects, vasopressin-induced overhydration leads to renal salt loss and negative sodium balance during the initial period of increasing body water before water balance is restored by a reduction in renal concentrating capacity. Both hlmodilution and renal salt loss contribute to the hyponatrmmia, but do not fully account for it particularly when overhydration is severe. Thus, in normal subjects with vasopressininduced overhydration and plasma sodium concentrations below 114 mEq/l., less than 50% of the fall in plasma sodium could be accounted for by changes in fluid and electrolyte balance (Stormont & Waterhouse 1961) . Under these circumstances there appears to be an intracellular shift of sodium which is presumed to result from inactivation of intracellular solute.
In patients with chronic SIADH, however, there appears to be an additional disturbance in electrolyte metabolism. As opposed to the reduction in body sodium which one might expect as a result of renal salt loss, in several patients with SIADH of varying etiology and with severe hyponatremia we have observed a normal or increased body sodium as judged by measurement of total exchangeable sodium isotopically. Total exchangeable potassium on the other hand was markedly reduced (see Table 1 ). These differential changes in body sodium and potassium suggest that overhydration may interfere with sodiumpotassium exchange across the cell membrane and result in an increase in sodium and reduction in potassium concentration within the cell.
Alternatively, or in addition, potassium depletion with chronic SIADH may be precipitated by slight but accumulative renal wasting ofpotassium over many months. This may depend upon the level of sodium intake. Reabsorption of sodium by the proximal tubules is reduced during vasopressin-mediated overhydration (Jones et al. 1963 ) and a high intake of sodium under these circumstances may lead to the delivery of very large amounts of sodium to the distal tubule, thus augmenting potassium exchange and excretion. In addition sodium potassium exchange in the distal nephron may be increased in SIADH by the presence of vasopressin, which directly increases the net reabsorption of sodium and reduces that of potassium by the renal tubules in man (Barraclough & Jones 1971 i.e. increasing the secretion of, or sensitivity to, vasopressin or acting on the same receptor in the renal tubule as vasopressin;
(2) a reduction in glomerular filtration rate; (3) a mechanism similar to that in thiazide-induced antidiuresis;
(4) increased renin levels; or (5) an antidipsiceffect.
Experiments on isolated toad bladder (Wales. 1971) using the technique described by Bentley (1958) show that chlorpropamide alone has nodirect effect on water transport across the bladder but potentiates the effect of small concentrationsof vasopressin. The metabolites of chlorpropamide are also effective in this respect but twoother sulphonylureas, acetohexamide and gliben-clamide, are not effective. Chlorpropamide does not potentiate the effect of dibutyryl-cyclic AMP in this preparation. However, chlorpropamide potentiates the effect of theophylline; the response in water transport when both drugs are incubated together is greater when chlorpropamide has been pre-incubated than when theophylline has been pre-incubated alone.
The efficacy of chlorpropamide in reducing urine output and symptoms and increasing urinary osmolality was demonstrated in 11 cases of diabetes insipidus of varying etiology.
In clinical experiments the response to a small dose of injected vasopressin (0-2 milliunits/kg i.v.) was the same, calculated on a percentage base, both before and after the administration of oral chlorpropamide. The overall clinical response and the response to vasopressin was essentially unchanged when chlorpropamide was taken on a high or low sodium intakeunlike the response to thiazides in diabetes insipidus. However, it is acknowledged that the response to prolonged infusions of a small dose of vasopressin may be different and may demonstrate a potentiating effect of chlorpropamide.
In 4 patients ethanol infusions before and after chlorpropamide-induced antidiuresis did not alter urine output significantly, thus suggesting that chlorpropamide does not act by increasing vasopressin secretion. No acute antidiuretic response to intravenous chlorpropamide could be demonstrated at a dose of 10 mg/kg. Hypoglycemia is the major side-effect of this therapy. Of the 11 adult patients treated, those with normal anterior pituitary function did not complain provided regular meals were taken. Of the 5 patients with anterior pituitary dysfunction only 2 could continue with chlorpropamide therapy even though all 5 patients were receiving adequate replacement therapy clinically. In two children, both with normal anterior pituitary function, one was adequately controlled while the other developed severe hypoglycemic symptoms with coma. This difficulty with children was noted by other workers (Ehrlich & Kooh 1970) .
It seems likely, therefore, that chlorpropamide potentiates the effect of small and normally ineffective concentrations of vasopressin to produce its clinical effect in diabetes insipidus but accurate measurements of circulating vasopressin will be required to confirm this. 
Effect of Intra-arterial Infusion ofRenal Extracts on Water Excretion
It was shown by de Bono et al. (1969) that infusions of protein extracts of dog kidneys into one renal artery of the dog caused a greater increase in excretion of sodium on the infused side than on the opposite side. At the same time there was impairment of renal concentration on the infused side while the opposite kidney still passed highly concentrated urine. Subsequently Barttet & Mills (1970) showed that the effect was present when the renal extracts were absorbed on to DEAE cellulose and eluted. The effect on sodium excretion did not correspond with blood pressure elevation and was presumed not to be due to renin.
In eighteen experiments involving infusion of renal protein extracts into the left renal artery, the mean rise in osmolar clearance was from 0 95 to 1-22 ml/min (P on paired values <0-001) with an associated fall in urine osmolality from (mean : S.E.) 1,295 ± 114 to 1,208 t 106 mosmol/kg. On paired values the mean difference was 160 + 56, P <0-02. On the right side the osmolality remained at 1,638 mosmol/kg. In 6 other experiments during the infusion of renal extract into the left renal artery, the latter was partially constricted proximal to the infusion point. The osmolality of the urine fell from a mean of 1,034 in the control period to 803 with the infusion and to 604 mosmol/kg during the constriction and the infusion (P on paired values <0 005 for the first fall and <0 05 for the second). There was an associated fall in the osmolar clearance from 1 6 to 1 25 ml/min but this latter was still above the control value (1 15). At the same time the sodium excretion, which had been increased by the infusion from 19 to 41 pEq/min (P <0 05), was reduced during the constriction to 31 pEq/min.
In two experiments partial renal artery constriction without infusion of renal extract led to a small fall in urinary osmolality on the constricted side but not on the opposite side. After release of the constriction the left kidney had a progressive fall in the urinary osmolality but the right did not.
It is concluded that the two effects of infusions of renal protein extracts into the renal artery, that is, a rise in sodium excretion and a fall in urine concentrating ability, are direct effects of the extract on the infused kidney, but that the sodium excretion can be decreased by lowering the renal perfusion pressure while such a proce-
